Ravi S Shukla,

Ravi S Shukla,

Central US Merck & Co., Inc. - Kenilworth / United States
Medical and Health Sciences / Pharmacy & Pharmaceutical Sciences
AD Scientific Index ID: 4484459
-
person_outline Ravi S Shukla,'s MOST POPULAR ARTICLES
1-) Development of a peptide–drug conjugate for prostate cancer therapyW Tai, RS Shukla, B Qin, B Li, K ChengMolecular pharmaceutics 8 (3), 901-912, 2011912011
2-) Peptides used in the delivery of small noncoding RNARS Shukla, B Qin, K ChengMolecular pharmaceutics 11 (10), 3395-3408, 2014722014
3-) Intracellular trafficking and exocytosis of a multi-component siRNA nanocomplexRS Shukla, A Jain, Z Zhao, K ChengNanomedicine: Nanotechnology, Biology and Medicine 12 (5), 1323-1334, 2016502016
4-) Development of a biocompatible copolymer nanocomplex to deliver VEGF siRNA for triple negative breast cancerZ Zhao, Y Li, R Shukla, H Liu, A Jain, A Barve, K ChengTheranostics 9 (15), 4508, 2019492019
5-) Development of streptavidin-based nanocomplex for siRNA deliveryRS Shukla, W Tai, R Mahato, W Jin, K ChengMolecular pharmaceutics 10 (12), 4534-4545, 2013302013